Filing Details

Accession Number:
0001628280-24-038211
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-22 16:02:27
Reporting Period:
2024-08-21
Accepted Time:
2024-08-22 16:02:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1699031 Grail Inc. GRAL Services-Medical Laboratories (8071) 863673636
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2024196 Aaron Freidin C/O Grail, Inc.
1525 O'Brien Drive
Menlo Park CA 94025
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-08-21 15,641 $16.25 173,429 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price calculated by the broker executing the sell-to-cover transactions. These shares were sold as part of a block trade in multiple transactions, and the Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price.